Showing results (71-80 of 129) with videos related to
Sort By:
Pageof 13
Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.Neuro-Degenerative Diseases|April 26, 2017
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive SubtypesBernhard Cerff, Walter Maetzler, Patricia Sulzer, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessmentMichael Lawton, Meike Kasten, Margaret T May, et al.NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.Neuropsychology|March 20, 2020
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.Frontiers in Neurology|July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's DiseaseEva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.Neurology|November 21, 2020
Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without DementiaSara Becker, Oliver Granert, Maarten Timmers, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2016
Vascular Risk Factors and Cognition in Parkinson's DiseaseAndrea Pilotto, Rosanna Turrone, Inga Liepelt-Scarfone, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 30, 2014
Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controlsMaartje Louter, Walter Maetzler, Jos Prinzen, et al.Pageof 13